ASX - By Stock
|
AVR |
Re:
another analytical technique
|
|
billcan
|
48 |
16K |
9 |
15/08/17 |
15/08/17 |
ASX - By Stock
|
48
|
16K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
another analytical technique
|
|
billcan
|
48 |
16K |
7 |
14/08/17 |
14/08/17 |
ASX - By Stock
|
48
|
16K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
another analytical technique
|
|
billcan
|
48 |
16K |
14 |
14/08/17 |
14/08/17 |
ASX - By Stock
|
48
|
16K
|
14
|
|
ASX - By Stock
|
TZL |
Re:
TZ Which Way Home?
|
|
billcan
|
1 |
979 |
0 |
14/08/17 |
14/08/17 |
ASX - By Stock
|
1
|
979
|
0
|
|
ASX - By Stock
|
TZL |
Re:
TZ Failure Delivered
|
|
billcan
|
5 |
4.2K |
1 |
14/08/17 |
14/08/17 |
ASX - By Stock
|
5
|
4.2K
|
1
|
|
ASX - By Stock
|
IMS |
Re:
Ann: Acquisition of C2B Solutions
|
|
billcan
|
28 |
10K |
3 |
14/08/17 |
14/08/17 |
ASX - By Stock
|
28
|
10K
|
3
|
|
ASX - By Stock
|
IMS |
Re:
C2B Solutions Pty Ltd
|
|
billcan
|
1 |
1.3K |
0 |
14/08/17 |
14/08/17 |
ASX - By Stock
|
1
|
1.3K
|
0
|
|
ASX - By Stock
|
IMS |
Re:
Ann: Acquisition of C2B Solutions
|
|
billcan
|
28 |
10K |
1 |
14/08/17 |
14/08/17 |
ASX - By Stock
|
28
|
10K
|
1
|
|
ASX - By Stock
|
IMS |
Re:
Ann: Acquisition of C2B Solutions
|
|
billcan
|
28 |
10K |
1 |
14/08/17 |
14/08/17 |
ASX - By Stock
|
28
|
10K
|
1
|
|
ASX - By Stock
|
IMS |
Re:
Ann: Acquisition of C2B Solutions
|
|
billcan
|
28 |
10K |
2 |
14/08/17 |
14/08/17 |
ASX - By Stock
|
28
|
10K
|
2
|
|
ASX - By Stock
|
IMS |
Re:
Ann: Acquisition of C2B Solutions
|
|
billcan
|
28 |
10K |
3 |
14/08/17 |
14/08/17 |
ASX - By Stock
|
28
|
10K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Answers from WP - a good read
|
|
billcan
|
315 |
89K |
0 |
11/08/17 |
11/08/17 |
ASX - By Stock
|
315
|
89K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Answers from WP - a good read
|
|
billcan
|
315 |
89K |
6 |
11/08/17 |
11/08/17 |
ASX - By Stock
|
315
|
89K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Answers from WP - a good read
|
|
billcan
|
315 |
89K |
5 |
11/08/17 |
11/08/17 |
ASX - By Stock
|
315
|
89K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Answers from WP - a good read
|
|
billcan
|
315 |
89K |
3 |
11/08/17 |
11/08/17 |
ASX - By Stock
|
315
|
89K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Answers from WP - a good read
|
|
billcan
|
315 |
89K |
2 |
11/08/17 |
11/08/17 |
ASX - By Stock
|
315
|
89K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Answers from WP - a good read
|
|
billcan
|
315 |
89K |
1 |
11/08/17 |
11/08/17 |
ASX - By Stock
|
315
|
89K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Answers from WP - a good read
|
|
billcan
|
315 |
89K |
0 |
11/08/17 |
11/08/17 |
ASX - By Stock
|
315
|
89K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Answers from WP - a good read
|
|
billcan
|
315 |
89K |
0 |
11/08/17 |
11/08/17 |
ASX - By Stock
|
315
|
89K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Answers from WP - a good read
|
|
billcan
|
315 |
89K |
1 |
11/08/17 |
11/08/17 |
ASX - By Stock
|
315
|
89K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Answers from WP - a good read
|
|
billcan
|
315 |
89K |
7 |
11/08/17 |
11/08/17 |
ASX - By Stock
|
315
|
89K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Answers from WP - a good read
|
|
billcan
|
315 |
89K |
4 |
09/08/17 |
09/08/17 |
ASX - By Stock
|
315
|
89K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Answers from WP - a good read
|
|
billcan
|
315 |
89K |
2 |
09/08/17 |
09/08/17 |
ASX - By Stock
|
315
|
89K
|
2
|
|
ASX - By Stock
|
TZL |
TZL CR
|
|
billcan
|
1 |
1.3K |
1 |
07/08/17 |
07/08/17 |
ASX - By Stock
|
1
|
1.3K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Answers from WP - a good read
|
|
billcan
|
315 |
89K |
5 |
04/08/17 |
04/08/17 |
ASX - By Stock
|
315
|
89K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Answers from WP - a good read
|
|
billcan
|
315 |
89K |
10 |
04/08/17 |
04/08/17 |
ASX - By Stock
|
315
|
89K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Answers from WP - a good read
|
|
billcan
|
315 |
89K |
3 |
04/08/17 |
04/08/17 |
ASX - By Stock
|
315
|
89K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Answers from WP - a good read
|
|
billcan
|
315 |
89K |
5 |
04/08/17 |
04/08/17 |
ASX - By Stock
|
315
|
89K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Admedus dominating in Europe.
|
|
billcan
|
89 |
21K |
12 |
02/08/17 |
02/08/17 |
ASX - By Stock
|
89
|
21K
|
12
|
|
ASX - By Stock
|
AVR |
Re:
Admedus dominating in Europe.
|
|
billcan
|
89 |
21K |
2 |
02/08/17 |
02/08/17 |
ASX - By Stock
|
89
|
21K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Admedus dominating in Europe.
|
|
billcan
|
89 |
21K |
3 |
02/08/17 |
02/08/17 |
ASX - By Stock
|
89
|
21K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Admedus dominating in Europe.
|
|
billcan
|
89 |
21K |
2 |
02/08/17 |
02/08/17 |
ASX - By Stock
|
89
|
21K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Admedus dominating in Europe.
|
|
billcan
|
89 |
21K |
4 |
02/08/17 |
02/08/17 |
ASX - By Stock
|
89
|
21K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Admedus dominating in Europe.
|
|
billcan
|
89 |
21K |
9 |
02/08/17 |
02/08/17 |
ASX - By Stock
|
89
|
21K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
Admedus dominating in Europe.
|
|
billcan
|
89 |
21K |
1 |
02/08/17 |
02/08/17 |
ASX - By Stock
|
89
|
21K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
billcan
|
160 |
48K |
0 |
28/07/17 |
28/07/17 |
ASX - By Stock
|
160
|
48K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
billcan
|
160 |
48K |
1 |
28/07/17 |
28/07/17 |
ASX - By Stock
|
160
|
48K
|
1
|
|
ASX - By Stock
|
IMS |
Re:
Ann: Resolution of Litigation
|
|
billcan
|
72 |
22K |
2 |
19/07/17 |
19/07/17 |
ASX - By Stock
|
72
|
22K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Infusion tender documents
|
|
billcan
|
11 |
2.9K |
0 |
19/07/17 |
19/07/17 |
ASX - By Stock
|
11
|
2.9K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Infusion tender documents
|
|
billcan
|
11 |
2.9K |
3 |
19/07/17 |
19/07/17 |
ASX - By Stock
|
11
|
2.9K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Infusion tender documents
|
|
billcan
|
11 |
2.9K |
4 |
19/07/17 |
19/07/17 |
ASX - By Stock
|
11
|
2.9K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Questions for Webinar
|
|
billcan
|
111 |
34K |
4 |
14/07/17 |
14/07/17 |
ASX - By Stock
|
111
|
34K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
billcan
|
1.2K |
445K |
5 |
14/07/17 |
14/07/17 |
ASX - By Stock
|
1.2K
|
445K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Share price
|
|
billcan
|
31 |
11K |
1 |
12/07/17 |
12/07/17 |
ASX - By Stock
|
31
|
11K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Share price
|
|
billcan
|
31 |
11K |
0 |
12/07/17 |
12/07/17 |
ASX - By Stock
|
31
|
11K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Update on the CardioCel 3D Product Launch
|
|
billcan
|
91 |
38K |
8 |
12/07/17 |
12/07/17 |
ASX - By Stock
|
91
|
38K
|
8
|
|
ASX - By Stock
|
IMS |
Re:
Multibagger primed for take off
|
|
billcan
|
151 |
59K |
2 |
10/07/17 |
10/07/17 |
ASX - By Stock
|
151
|
59K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
3D Announcement Next 48hours
|
|
billcan
|
20 |
6.2K |
7 |
07/07/17 |
07/07/17 |
ASX - By Stock
|
20
|
6.2K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Pent up selling
|
|
billcan
|
2 |
1.0K |
3 |
07/07/17 |
07/07/17 |
ASX - By Stock
|
2
|
1.0K
|
3
|
|
ASX - By Stock
|
AVR |
Pent up selling
|
|
billcan
|
2 |
1.0K |
0 |
05/07/17 |
05/07/17 |
ASX - By Stock
|
2
|
1.0K
|
0
|
|